MDxHealth is trading 5.01% up at $0.79, supported primarily by healthcare-sector strength as positive cancer-vaccine trial news improved biotechnology sentiment.
- Rebounded from the August 18, 2026 close of $0.75.
- No new company-specific announcement was identified for August 19, 2026; recent coverage focused on second-quarter results, including 16% revenue growth and reaffirmed 2026 guidance.
- Healthcare stocks gained 1.90%; trading included a 74.89% gain on August 14 and a 12.20% decline on August 18.